<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Ibandronic acid; Iasibon (ibandronic acid); Bondronat; Ibandronic acid; Bonviva preparations; Ibandronic acid; Bonviva preparations; Ibandronic acid" /><meta name="IX" content="Iasibon (ibandronic acid); Bondronat; Ibandronic acid; Bonviva preparations; Ibandronic acid; Bonviva preparations; Ibandronic acid" /><meta name="IXM" content="Ibandronic acid" /><title>IBANDRONIC ACID: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP4671-ibandronic-acid.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP4671-ibandronic-acid.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP4671-ibandronic-acid.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP4031-endocrine-system.htm">6 Endocrine system</a> &gt; <a href="PHP4642-drugs-affecting-bone-metabolism.htm">6.6 Drugs affecting bone metabolism</a> &gt; <a href="PHP4652-bisphosphonates-and-other-drugs-affecting-bone-metabolism.htm">6.6.2 Bisphosphonates and other drugs affecting bone metabolism</a> &gt; <a href="PHP4653-bisphosphonates.htm">Bisphosphonates</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP4668-disodium-pamidronate.htm" title="Previous: DISODIUM PAMIDRONATE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP4672-ibandronic-acid-non-proprietary.htm#PHP4672-ibandronic-acid-non-proprietary" title="Next: Ibandronic acid">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a305018.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronate Sodium</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Bone Resorption Inhibitors 92:24</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/22527-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ibandronate</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Ibandronate</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="PHP4672-ibandronic-acid-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic acid </a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.6 Drugs affecting bone metabolism &gt; 6.6.2 Bisphosphonates and other drugs affecting bone metabolism &gt; Bisphosphonates &gt; IBANDRONIC ACID</p></div></li><li><a href="PHP4673-bondronat.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bondronat®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.6 Drugs affecting bone metabolism &gt; 6.6.2 Bisphosphonates and other drugs affecting bone metabolism &gt; Bisphosphonates &gt; IBANDRONIC ACID</p></div></li><li><a href="PHP4674-bonviva.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Bonviva®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 6 Endocrine system &gt; 6.6 Drugs affecting bone metabolism &gt; 6.6.2 Bisphosphonates and other drugs affecting bone metabolism &gt; Bisphosphonates &gt; IBANDRONIC ACID</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22ibandronic+acid%22%22ibandronic+acid%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK-TD-c157-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic Acid</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; I</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/I01-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic acid</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-22527-n.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronate</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Bone Modulating Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04873.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic Acid</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IB</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-I1.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronate Sodium</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; I</p></div></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-I2.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic Acid</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; I</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E18E3E0R0D3142.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Ibandronate</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c398.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Ibandronic acid</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; I</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>IBANDRONIC ACID</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int955-ibandronic-acid.htm">Ibandronic Acid</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see under Dose</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">consider dental check-up before initiating bisphosphonate (risk of osteonecrosis of the jaw, see <a title="BNF:target-block: Bisphosphonates NICE guidance" href="PHP4653-bisphosphonates.htm#PHP4654">Bisphosphonates: Osteonecrosis of the Jaw</a>); atypical femoral fractures, see <a title="BNF:target-block: Atypical femoral fractures" href="PHP4653-bisphosphonates.htm#PHP4655">MHRA/CHM advice</a>; monitor renal function and serum calcium, phosphate and magnesium; cardiac disease (avoid fluid overload); <strong>interactions:</strong> Appendix 1 (bisphosphonates)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">hypocalcaemia; <em>oral route</em> abnormalities of the oesophagus and other factors which delay emptying (e.g. stricture or achalasia)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">for treatment of osteoporosis, avoid if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>; for reduction of bone damage in bone metastases, if eGFR 30–50 mL/minute/1.73 m<sup>2</sup> reduce <em>intravenous dose</em> to 4 mg and infuse over 1 hour, reduce <em>oral dose</em> to 50 mg on alternative days, if eGFR less than 30 mL/minute/1.73 m<sup>2</sup> reduce <em>intravenous dose</em> to 2 mg and infuse over 1 hour, reduce <em>oral dose</em> to 50 mg once weekly</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">avoid</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">avoid—present in milk in <em>animal</em> studies</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">hypocalcaemia, hypophosphataemia, influenza-like symptoms (including fever, chills, and muscle pain), bone pain; oesophageal reactions (see below), diarrhoea, nausea, vomiting, gastritis, abdominal pain, dyspepsia, pharyngitis; headache, asthenia, rash; <em>rarely</em> anaemia, atypical femoral fractures (see <a title="BNF:target-block: Atypical femoral fractures" href="PHP4653-bisphosphonates.htm#PHP4655">MHRA/CHM advice</a>), hypersensitivity reactions (pruritus, bronchospasm and angioedema reported); urticaria; injection-site reactions; <em>very rarely</em> osteonecrosis of the jaw (see <a title="BNF:target-block: Bisphosphonates NICE guidance" href="PHP4653-bisphosphonates.htm#PHP4654">Bisphosphonates: Osteonecrosis of the Jaw</a>)</p></div> <div class="cG"><div class="cE"><h3 class="cT">Oesophageal reactions</h3> <p class="cT">Severe oesophageal reactions reported with all <strong>oral</strong> bisphosphonates; patients should be advised to stop tablets and seek medical attention for symptoms of oesophageal irritation such as dysphagia, pain on swallowing, retrosternal pain, or heartburn</p></div></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Reduction of bone damage in bone metastases in breast cancer, <span class="cK">by mouth</span>, 50 mg daily,<em> or </em><span class="cK">by intravenous infusion</span>, 6 mg every 3–4 weeks</p></li> <li><p>Hypercalcaemia of malignancy <span class="cK">by intravenous infusion</span>, according to serum calcium concentration, 2–4 mg in single infusion </p></li> <li><p>Treatment of postmenopausal osteoporosis, <span class="cK">by mouth</span>, 150 mg once a month <em>or</em> <span class="cK">by intravenous injection</span> over 15–30 seconds, 3 mg every 3 months</p></li> <li><p><span class="cP">child</span> not recommended</p></li>  </ul><div class="cG"><div class="cE"><h3 class="cT">Counselling</h3> <p class="cT">Tablets should be swallowed whole with plenty of water while sitting or standing; to be taken on an empty stomach at least 30 minutes (ibandronic acid tablets, 50 mg) or 1 hour (<em>Bonviva</em>® tablets, 150 mg) before first food or drink (other than water) of the day, or another oral medicine; patient should stand or sit upright for at least 1 hour after taking tablet</p></div></div></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP4672-ibandronic-acid-non-proprietary.htm#PHP4672-ibandronic-acid-non-proprietary" title="Ibandronic acid ">Ibandronic acid </a></li><li><a href="PHP4673-bondronat.htm#PHP4673-bondronat" title="Bondronat®">Bondronat®</a></li><li><a href="PHP4674-bonviva.htm#PHP4674-bonviva" title="Bonviva®">Bonviva®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP4668-disodium-pamidronate.htm">Previous: DISODIUM PAMIDRONATE</a> | <a class="top" href="PHP4671-ibandronic-acid.htm#">Top</a> | <a accesskey="]" href="PHP4672-ibandronic-acid-non-proprietary.htm#PHP4672-ibandronic-acid-non-proprietary" title="Ibandronic acid">Next: Ibandronic acid</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>